A new lung cancer surgery method stirs debate; White House links drug pricing law to lower cancer death rates

A new type of lung-sparing surgery is starting to gain traction, and support through studies. But the details are fiercely debated among surgeons. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      In the fiercely competitive world of health care, blockchain technology is quickly becoming the next frontier. Get up to speed with our latest STAT Report, a guide to blockchain in health care. Surgeons often take a fifth of the lungs to remove a small tumor. There may be a better way By Angus Chen Laura Brown for STAT A new type of lung-sparing surgery is starting to gain traction, and support through studies. But the details are fiercely debated among surgeons. Read More STAT+: White House pitches drug pricing reforms as a way to extend cancer patients' lives By Rachel Cohrs Anna Moneymaker/Getty Images The White House is pitching an added benefit to Democrats’ recent drug pricing reform package: lower cancer death rates. Read More Shakeup with Optum's health data licensing sparks an outcry among scientists By Casey Ross Adobe A move by Optum to change longstanding practices for licensing data to academic institutions has sparked an outcry among researchers. Read More Sponsor content by Pandemic Response Lab Why test for co-infections? 5 ways syndromic PCR panels can improve patient outcomes Traditional diagnostics targeting a single pathogen can delay treatment while increasing costs for providers and patients. Multiplex PCR technology—already used to detect respiratory co-infections, STIs, and more—can accurately identify infections or co-infections quickly and cost-effectively and prevent further spread of infectious disease, thereby improving patient care and overall health outcomes. Learn more about the benefits of syndromic PCR panels. Opinion: Gender-affirming care should be embraced, not met with vitriol and bomb threats By Carole Allen JOSEPH PREZIOSO/AFP via Getty Images Gender-affirming care is a thoughtful approach to individuals whose gender identity doesn't correspond to the sex assigned them at birth. Read More STAT+: Inflation caused another big drop in net drug prices, analysis finds By Ed Silverman APStock The so-called gross-to-net bubble — which measures the gap between gross sales at list prices and net prices after rebates — was 48.5%. Read More STAT+: Solicitor general recommends Supreme Court shouldn't review an Amgen patent case By Ed Silverman Anna Moneymaker/Getty Images “The solicitor general explained this case was not a good vehicle for addressing the legal questions presented," said Nicholas Mitrokostas. Read More Opinion: Market share isn't the only metric for biosimilars' success By Jeff Baldetti BRENDAN SMIALOWSKI/AFP/GettyImages Market share is a good metric for the success of a biosimilar class. Lower average sales prices across a therapeutic category is another one. Read More Friday, September 23, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser